Tolerance induction to cultured islet allografts: II. the status of antidonor reactivity in tolerant animals

Transplantation

Volumn 57, Issue 8, 1994, Pages 1201-1207

  Coulombe, Marilyne ^a   Gill, Ronald G ^a  

^a UNIVERSITY OF COLORADO DENVER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

GAMMA INTERFERON; INTERLEUKIN 2; INTERLEUKIN 3; TUMOR NECROSIS FACTOR;

ANIMAL MODEL; ANIMAL TISSUE; ANTIGEN PRESENTATION; ARTICLE; CONTROLLED STUDY; IMMUNOLOGICAL TOLERANCE; IMMUNOREACTIVITY; IMMUNOREGULATION; MALE; MOUSE; NONHUMAN; PANCREAS ISLET TRANSPLANTATION; PRIORITY JOURNAL; T LYMPHOCYTE ACTIVATION;

ANIMAL; ANTIGEN-PRESENTING CELLS; CELLS, CULTURED; GRAFT ENHANCEMENT, IMMUNOLOGIC; GRAFT REJECTION; HISTOCOMPATIBILITY ANTIGENS CLASS I; IMMUNE TOLERANCE; ISLETS OF LANGERHANS TRANSPLANTATION; LYMPHOCYTE ACTIVATION; MALE; MICE; MICE, INBRED C57BL; MICE, INBRED CBA; MICE, SCID; RECEPTORS, ANTIGEN, T-CELL; SUPPORT, NON-U.S. GOV'T; SUPPORT, U.S. GOV'T, P.H.S.; T-LYMPHOCYTES;

EID: 0028217424     PISSN: 00411337     EISSN: None     Source Type: Journal    
DOI: 10.1097/00007890-199404270-00011     Document Type: Article

References (46)

1. Lafferty KJ, Prowse SJ, Simeonovic CJ. Immunology of tissue transplantation: a return to the passenger leukocyte concept. Annu Rev Immunol 1983; 1: 143.
2. Jenkins MK, Schwartz RH. Antigen presentation by chemically modified splenocytes induces antigen-specific T cell unresponsiveness in vitro and in vivo. J Exp Med 1987; 165: 302.
3. Burkly LC, Lo D, Flavell RA. Tolerance in transgenic mice ex pressing major histocompatibility molecules extrathymically on pancreatic cells. Science 1990; 248: 1364.
4. Miller JFAP, Morahan G. Peripheral T cell tolerance. Annu Rev Immunol 1992; 10: 51.
5. Prowse SJ, Lafferty KJ, Simeonovic CJ, et al. The reversal of diabetes by pancreatic islet transplantation. Diabetes 1982; 31: 30.
6. Talmage DW, Woolnough JA, Hemmingsen H, et al. Activation of cytotoxic T cells by nonstimulating tumor cells and spleen cell factor(s). Proc Natl Acad Sci USA 1977; 74: 1610.
7. Bowen KM, Prowse SJ, Lafferty KJ. Reversal of diabetes by islet transplantation: vulnerability of the established allograft. Science 1981; 213: 1261.
8. Coulombe M, Gill RG. Tolerance induction to cultured islet al lografts: I. Characterization of the tolerant state. Transplantation 1994; 57: 1195.
9. Donohoe JA, Andrus L, Bowen KM, et al. Cultured thyroid al-lografts induce a state of partial tolerance in adult recipient mice. Transplantation 1983; 35: 62.
10. Rollinghoff M, Warner NL. Specificity of in vivo tumor rejection assessed by mixing immune spleen cells with target and unrelated tumor cells. Proc Soc Exp Biol Med 1973; 144: 813.
11. Dexter TM, Garland J, Scott D, et al. Growth of factor-dependent hemopoietic precursor cell lines. J Exp Med 1980; 152: 1036.
12. Prowse SJ, Simeonovic CJ, Lafferty KJ, et al. Allogeneic islet transplantation without recipient immunosuppression. In: Larner J, Pohl SL, eds. Methods in diabetes research, vol. I. New York: Wiley, 1984: 253.
13. Scharp DW, Kemp CB, Knight MJ, et al. The use of ficoll in the preparation of viable islets of Langerhans from the rat pancreas. Transplantation 1973; 16: 686.
14. Gill RG, Babcock SK, Lafferty KJ. A quantitative analysis of antigen-triggered lymphokine production by activated T cells. J Immunol 1987; 138: 1130.
15. Woolnough JA, Lafferty KJ. Generation of homogeneous popu lations of alloreactive T cells in vitro. Aust J Exp Biol Med Sci 1979; 57: 127.
16. Taswell C. Limiting dilution assays for the determination of immunocompetent cell frequencies: I. Data analysis. J Immunol 1981; 126: 1614.
17. Haskins K, Portas M, Bradley B, et al. T-lymphocyte clone spe cific for pancreatic islet antigen. Diabetes 1988; 37: 1444.
18. Mosmann T. Rapid colorimetric assay for cellular growth and survival: application to proliferation and cytotoxicity assays. J Immunol Methods 1983; 65: 55.
19. Parr EL, Bowen KM, Lafferty KJ. Cellular changes in cultured mouse thyroid glands and islets of Langerhans. Transplantation 1980; 30: 135.
20. + cells triggers acute rejection of pancreatic islet allografts. Aust J Exp Biol Med Sci 1983; 61: 181.
21. Hao L, Wang Y, Gill RG, et al. Role of lymphokine in islet allograft rejection. Transplantation 1990; 49: 609.
22. Parr EL, Lafferty KJ, Bowen KM, et al. H-2 complex and la antigens on cells dissociated from mouse thyroid glands and islets of Langerhans. Transplantation 1980; 30: 142.
23. Kappler J, Roehm N, Marrack P. T cell tolerance by clonal elimi nation in the thymus. Cell 1987; 49: 273.
24. + thymocytes. Nature 1988; 333: 742.
25. McCullagh P. Curtailment of autoimmunity following parabiosis with a normal partner. Immunology 1990; 71: 595.
26. Marrack P, Kappler J. T cells can distinguish between allogeneic major histocompatibility complex products on different cell types. Nature 1988; 332: 840.
27. Guerder S, Matzinger P. A fail-safe mechanism for maintaining self-tolerance. J Exp Med 1992; 176: 553.
28. Agostino M, Prowse SJ, Lafferty KJ. Stabilization of islet al lografts by treatment of recipients with ultraviolet irradiated donor spleen cells. Aust J Exp Biol Med Sci 1983; 61: 517.
29. Morahan G, Allison J, Miller JFAP. Tolerance of class I histo compatibility antigens expressed extrathymically. Nature 1989; 339: 622.
30. Schonrich G, Kalinke U, Momberg F, et al. Down-regulation of T cell receptors on self-reactive T cells as a novel mechanism for extrathymic tolerance induction. Cell 1991; 65: 293.
31. Allison J, Campbell IL, Morahan G, et al. Diabetes in transgenic mice resulting from over-expression of class I histocompatibility molecules in pancreatic β cells. Nature 1988; 333: 529.
32. Sarvetnick N, Liggitt D, Pitts SL, et al. Insulin-dependent dia betes mellitus induced in transgenic mice by ectopic expression of class II MHC and interferon-gamma. Cell 1988; 52: 773.
33. Lo D, Burkly LC, Widera G, et al. Diabetes and tolerance in transgenic mice expressing class II MHC molecules in pancreatic beta cells. Cell 1988; 53: 159.
34. Bohme J, Haskins K, Stecha P, et al. Transgenic mice with I-A on islet cells are normoglycemic but immunologically intolerant. Science 1989; 244: 1179.
35. Miller J, Daitch L, Rath S, et al. Tissue-specific expression of allogeneic class II MHC molecules induces neither tissue rejection nor clonal inactivation of alloreactive T cells. J Immunol 1990; 144: 334.
36. Heath WR, Allison J, Hof Tamnn MW, et al. Autoimmune diabe tes as a consequence of locally produced interleukin-2. Nature 1992; 359: 547.
37. Husbands SD, Schonrich G, Arnold B, et al. Expression of major histocompatibility complex class I antigens at low levels in the thymus induces T cell tolerance via a non-deletional mechanism. Eur J Immunol 1992; 22: 2655.
38. Morahan G, Brennan FE, Bhathal PS, et al. Expression in trans genic mice of class I histocompatibility antigens controlled by the metallothionein promoter. Proc Natl Acad Sci USA 1989; 86: 3782.
39. Murphy KM, Weaver CT, Elish M, et al. Peripheral tolerance to allogenic class II histocompatibility antigens expressed in transgenic mice: evidence against a clonal deletion mechanism. Proc Natl Acad Sci 1989; 86: 10034.
40. Dallman MJ, Wood KJ, Morris PJ. Specific cytotoxic T cells are found in the nonrejected kidneys of blood-transfused rats. J Exp Med 1987; 165: 566.
41. Dallman MJ, Shiho O, Page TH, et al. Peripheral tolerance to alloantigen results from altered regulation of the interleukin 2 pathway. J Exp Med 1991; 173: 79.
42. Mohler KM, Streilein JW. Tolerance to class II major histocom patibility complex molecules is maintained in the presence of endogenous, interleukin 2-producing, tolerogen-specific T lymphocytes. J Immunol 1987; 139: 2211.
43. La Rosa FG, Smilek D, Talmage DW, et al. Evidence that toler ance to cultured thyroid allografts is an active immunological process. Transplantation 1992; 53: 903.
44. Qin S, Cobbold SP, Pope H, et al. "Infectious" transplantation tolerance. Science 1993; 259: 974.
45. Hall BM, Jelbart ME, Gurley KE, et al. Specific unresponsive ness in rats with prolonged cardiac allograft survival after treatment with cyclosporine: mediation of specific suppression by T helper/inducer cells. J Exp Med 1985; 162: 1683.
46. Hall BM. Mechanisms maintaining enhancement of allografts: I. Demonstration of a specific suppressor cell. J Exp Med 1985; 161: 123.